Author:
Buchholz Christian J.,Hartmann Jessica,Schüßler-Lenz Martina,Keller-Stanislawski Brigitte
Publisher
Deutscher Arzte-Verlag GmbH
Reference14 articles.
1. Roberts ZJ, et al.: Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL. Leuk Lymphoma 2017; 23: 1–12
2. Hartmann J, et al.: Clinical development of CAR T cells – challenges and opportunities in translating innovative treatment concepts. EMBO molecular medicine 2017; 9: 1183–97
3. FDA: Beipackinformation YESCARTA. https://www.fda.gov/downloads/Biologics-BloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM581226.pdf (last accessed on 5 February 2018).
4. FDA: Beipackzettel KYMRIAH. https://www.fda.gov/downloads/Biologics-BloodVaccines/CellularGeneThe-rapyProducts/ApprovedProducts/UCM573941.pdf (last accessed on 5 February 2018).
5. Bonifant CL, et al.: Toxicity and management in CAR T-cell thera-py. Mol Ther Oncolytics 2016; 3: 16011
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献